Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
33 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

Science


RSS FeedsNovartis`s Rydapt wins EU approval for AML, other diseases
(Reuters Health)

 
 

20 september 2017 07:47:27

 
Novartis`s Rydapt wins EU approval for AML, other diseases
(Reuters Health)
 


ZURICH (Reuters) - Swiss drugmaker Novartis on Wednesday said it had won European Union approval for Rydapt to be used against a mutated form of acute myeloid leukemia (AML) and other rare diseases, adding to U.S. approvals it secured in April.


 
12 viewsCategory: Science > Medicine
 
PTSD linked with increased lupus risk
(PHYSorg.com Medicine & Health)
The big question: Will cancer immune therapy work for me?
(WorldNews Health)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten